Trial Profile
A Study to Compare the Efficacy and Safety of Infliximab and Adalimumab in Patients With Ulcerative Colitis (UC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Mar 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 22 Mar 2016 New trial record
- 15 Mar 2016 Results published in the Alimentary Pharmacology and Therapeutics